Disease Diagnostic Group: Saving lives with just refrigerator magnets and laser pointers
Example: Walk us through a specific example(s) of how this solution makes a difference; include its primary activities.
Impact: What is the impact of the work to date? Also describe the projected future impact for the coming years.
Spread Strategies: Moving forward, what are the main strategies for scaling impact?
Financial Sustainability Plan: What is this solution’s plan to ensure financial sustainability?
Marketplace: Who else is addressing the problem outlined here? How does the proposed project differ from these approaches?
Founding Story
Team
Personal connections
Founder/CEO
No Poverty, Decent Work and Economic Growth.
I am confident that I have the entrepreneurial skills and resourcefulness to generate enough interest in the organization to sustain it. First, I have raised money for two other startups in the past, a hedge fund named Lew & Dowski that attracted investors into the fund and has healthy returns albeit on a relatively small net asset value and Recon Therapeutics, which commercialized a onestep reconstitution device for lyophilized drugs. I also have created a support network of partners and advisors around this magnetooptical device ranging from universities to companies that have previously financially and clinically supported us and will continue to do so in the future. The credibility in the malaria ecosystem that I have achieved is extremely important, especially for an earlystage diagnostic company. I am a terrific grant writer and have been very successful raising nostrings attached money that can allow for a flexible business plan.
Although we yet to finalize an official board of advisors, the promise of our technology has attracted many high profile individuals who are extremely happy to offer support on business, technical, clinical, and legal issues. Among our many informal advisors who we speak to every couple months are Scott Filler (Head of Malaria at The Global Fund), Theodoor Visser (Malaria Diagnostic Manager at Clinton Health Access Initiative), Martin Edlund (CEO of Malaria No More), David Bell (Previous Director of Infectious Disease at FIND), Paul LaBarre (Senior Technical Officer for Diagnostics at PATH), and Bill Rodriguez (CMO of FIND). Two of the key advisor sets to us are the management teams at Daktari Diagnostics and T2 Biosystems in Cambridge, MA. They have successfully commercialized a portable HIV/CD4 counting device for the developing world and have directed us on exact partnerships and funding opportunities to exploit. DDG is a member of the JumpStart Mentoring Program in Cleveland, OH and the Venture Mentoring Service in Cambridge, MA. Through various programs we have access to up to 30 hours of free legal, financial, and business consulting
services every month.